Clinical Trials Browser

Phase 2 × PROSTVAC × 1 year × Clear all

NCT03315871 2025-06-19

Combination Immunotherapy in Biochemically Recurrent Prostate Cancer

Phase 2 Completed

40 enrolled 14 charts

Prostatic Neoplasms